Effect of trimetazidine (20 and 30 mg/kg) on elevated plus maze behavior of rodents was assessed in the genetic and pharmacological anxiety models. Single intraperitoneal injection of trimetazidine in a dose of 20 mg/kg prevented anxiety development in highly emotional male BALB/c mice and increased the time spent in open arms of the maze. In outbred male rats receiving 10% ethanol solution for 20 weeks, trimetazidine administered intraperitoneally in a dose of 20 mg/kg for 28 days abolished ethanol withdrawal-induced anxiogenesis developed against the background of 4-week alcohol deprivation: it increased the time spent in open arms, the number of entries into open arms, and total locomotor activity in the maze. Anxiolytic properties of trimetazidine were not inferior to those of the non-benzodiazepine anxiolytic Afobazole (fabomotizole) in acute and chronic administration.
Similar content being viewed by others
References
Kolik LG, Nadorova AV, Kozlovskaya MM. Efficacy of peptide anxiolytic selank during modeling of withdrawal syndrome in rats with stable alcoholic motivation. Bull. Exp. Biol. Med. 2014;157(1):52-55.
Kryzhanovskii SA, Stolyaruk VN, Vititnova MB, Tsorin IB, Seredenin SB. Pleiotropic (cardiotropic) effects of anxiolytic Afobazole (rewiew of experimental studies). Terapevt. 2012;(1):32-40. Russian.
Bertolucci-D’Angio M, Serrano A, Scatton B. Mesocorticolimbic dopaminergic systems and emotional states. J. Neurosci. Methods. 1990;34(1-3):135-142.
Brücke T, Wöber C, Podreka I, Wöber-Bingöl C, Asenbaum S, Aull S, Wenger S, Ilieva D, Harasko van der Meer C, Wessely P, Deecke L. D2 receptor blockade by flunarizine and cinnarizine explains extrapyramidal side effects. A SPECT study. J. Cerebr. Blood Flow Metab. 1995;15(3):513-518.
Erbaş O, Akseki HS, Eliküçük B, Taşkıran D. Antipsychoticlike effect of trimetazidine in a rodent model. Scientifi c World J. 2013. ID 686304.
Huang MC, Chen CC, Peng FC, Tang SH, Chen CH. The correlation between early alcohol withdrawal severity and oxidative stress in patients with alcohol dependence. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2009;33(1):66-69.
Joshi D, Naidu PS, Singh A, Kulkarni SK. Protective effect of quercetin on alcohol abstinence-induced anxiety and convulsions. J. Med. Food. 2005;8(3):392-396.
Kumar A, Kaur G, Kalonia H, Rinwa P. Evaluation of sesamol and buspirone in stress induced anxiety in mice. Indian J. Pharmacol. 2013;45(1):49-53.
Lopatin YM, Rosano GM, Fragasso G, Lopaschuk GD, Seferovic PM, Gowdak LH, Vinereanu D, Hamid MA, Jourdain P, Ponikowski P. Rationale and benefi ts of trimetazidine by acting on cardiac metabolism in heart failure. Int. J. Cardiol. 2016;203:909-915.
Masmoudi K, Masson H, Gras V, Andréjak M. Extrapyramidal adverse drug reactions associated with trimetazidine: a series of 21 cases. Fundam. Clin. Pharmacol. 2012;26(2):198-203.
Nakhaee A, Shahabizadeh F, Erfani M. Protein and lipid oxidative damage in healthy students during and after exam stress. Physiol. Behav. 2013;118:118-121.
Pavlova IV, Rysakova MP, Sergeeva MI. Influence of D1, D2 receptor blockade in basolateral amygdala on behavior of rats with high or low levels of anxiety and fear. Zh. Vyssh. Nerv. Deiat. Im. I. P. Pavlova. 2015;65(4):471-485.
Piri M, Ayazi E, Zarrindast MP. Involvement of the dorsal hippocampal dopamine D2 receptors in histamine-induced anxiogenic-like effects in mice. Neurosci. Lett. 2013;550:139-144.
Wu Q, Qi Y, Liu Y, Cheng B, Liu L, Li Y, Wang Q. Mechanisms underlying protective effects of trimetazidine on endothelial progenitor cells biological functions against H2O2-induced injury: involvement of antioxidation and Akt/eNOS signaling pathways. Eur. J. Pharmacol. 2013;707(1-3):87-94.
Zhao Y, Weiss F, Zorrilla EP. Remission and resurgence of anxiety-like behavior across protracted withdrawal stages in ethanol-dependent rats. Alcohol Clin. Exp. Res. 2007;31(9):1505-1015.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 162, No. 11, pp. 593-597, November, 2016
Rights and permissions
About this article
Cite this article
Kolik, L.G., Nadorova, A.V., Stolyaruk, V.N. et al. Anxiolytic Properties of Trimetazidine in Experimental Models of Increased Anxiety. Bull Exp Biol Med 162, 643–646 (2017). https://doi.org/10.1007/s10517-017-3677-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-017-3677-2